Advanced biologics and patient-specific therapies reduce opportunities for terminal sterilization, elevating proactive microbial risk control and integrating QC microbiology into CCS authorship, risk ...

Contract development and manufacturing organizations can assist sponsor company is ensuring sterility assurance in alignment with the EU’s Annex 1 guidelines. The 2023 revision of Annex 1 of the ...

When looking for a contamination control strategy for your aseptic processes, consider a partner who has the expertise to answer your questions, support your project from start to finish, and then ...

Pharmaceutical manufacturers engaged in biotechnology, pharmaceutical, medical device, home and personal care, and other related manufacturing industries need to be meticulous in creating and ...

Correction: This article was edited on 15 September 2022 to correct Jorg Zimmermann's title. Sterile drug manufacturers should start preparing a gap analysis to identify what needs to be done to ...

As EV battery manufacturing technologies evolve, from coated film to solid-state cells, the industry is facing new contamination challenges that existing processes aren’t equipped to handle. According ...

AUSTIN, Texas, April 07, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: Pharmaceutical manufacturing is undergoing a structural shift as regulators demand higher standards for contamination ...

ZHONGSHAN CITY, GUANGDONG PROVINCE, CHINA, March 19, 2026 /EINPresswire.com/ — In industries where a single particle can compromise an entire production batch ...

Dublin, April 10, 2026 (GLOBE NEWSWIRE)-- The "New EU GMP Annex 1: Compliant Sterile Medicinal Products (May 19th - May 23rd, 2026)" training has been added to ResearchAndMarkets.com's offering. The ...